State of Wisconsin Investment Board’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
TCM
NMC
State of Wisconsin Investment Board's AUPH Position: Q1 2026 in Review
State of Wisconsin Investment Board reduced its Aurinia Pharmaceuticals (AUPH) stake by 0.3% in Q1 2026, selling an estimated $9.03K and leaving 204,006 shares worth $3.02M. The position accounts for 0.01% of the portfolio, ranked #1201.
State of Wisconsin Investment Board first reported a position in AUPH in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.26M in Q4 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.
- State of Wisconsin Investment Board held 204,006 shares of Aurinia Pharmaceuticals worth $3.02M as of Q1 2026.
- State of Wisconsin Investment Board sold 618 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $9.03K.
- Aurinia Pharmaceuticals made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1201 holding.
- State of Wisconsin Investment Board first reported a position in Aurinia Pharmaceuticals in Q1 2022 and has held it in 17 quarters since.
- State of Wisconsin Investment Board's Aurinia Pharmaceuticals position peaked at $3.26M in Q4 2025.
- 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.